UPC CFI 106/2025
Feb 28, 2025·EP3156843: DEVICE AND METHOD FOR THREE-DIMENSIONAL RECONSTRUCTION OF THE HEAD AND BODY
Parent infringement case:UPC CFI 559/2024
- Case details
- StatusOral PhaseActionCounterclaim for revocationCategoryCounter Claim for Revocation
- Parties
- Claimants
- Canfield Scientific GmbH
- Canfield Scientific s.r.l.
- ESTHETEC SAS
- Canfield Scientific Europe B.V.
- Canfield Scientific, Inc.
Reps: Felix Klopmeier (Lang & Rahmann Rechtsanwälte PartG mbB); null (Michalski, Hüttermann & Partner)RespondentsReps: Miriam Kiefer, Ll.m. (Kather Augenstein); Benjamin Pesch (Kather Augenstein); Benedikt Walesch, Ll.m. (Kather Augenstein); Bernhard Thum (Thum & Partner) - Division
- Dusseldorf LD
- Technology
- Medical Devices · Imaging · Computing & AI
- Language
- German
- First decided
- Apr 23, 2026
- 2026-04-23Permanent injunctionRevocation meritsCounterclaim for revocation
The UPC Local Division Düsseldorf found that EP 3 156 843 (a stereophotogrammetry device and method for 3D body reconstruction) was directly infringed by the respondents' Canfield Vectra H2 imaging system in Belgium, France, Italy, and the Netherlands. The court granted an injunction, recall, removal from distribution channels, disclosure of information, provisional damages of EUR 20,000, and a declaration of liability for further damages, while dismissing the defendants' counterclaim for revocation in its entirety.
Legal issues:Infringement of claims 1 and 14 of EP 3 156 843 by Canfield Vectra H2 stereophotogrammetry systemTerritorial scope of UPC injunction under Art. 34 UPCA including 'carve out' of Germany due to parallel German proceedingsClaim construction: whether dual optics require two separate optical systems without moving partsClaim construction: whether the signalling of target distance requires two temporally separate stepsValidity of EP 3 156 843: lack of inventive step counterclaim by respondentsStanding/passive legitimation of Defendant 1 (German subsidiary) for acts in other contracting member statesLimitation/prescription under Art. 72 UPCA for damages and ancillary claimsProvisional damages under R. 119 RoPProvisional reimbursement of costs under R. 150.2 RoPSecurity for enforcement under Art. 82(2) UPCAConfidentiality order as condition precedent to disclosure obligationDamages: 20,000
| Document title | Date | Public |
|---|---|---|
| Receipt | 2026-05-18 | Not public |
| Cover sheet | 2026-05-18 | Not public |
| Exhibit Applicant | 2026-05-18 | Not public |
| Application document Applicant | 2026-05-18 | Not public |
| action.phaseChange.caseClose | 2026-04-23 | Not public |
| action.issueDecision.decision | 2026-04-23 | Not public |
| Decision | 2026-04-23 | Public |
| Hearing recording reference document | 2026-03-13 | Not public |
| Receipt | 2026-03-11 | Not public |
| Cover sheet | 2026-03-11 | Not public |
| Document Claimant | 2026-03-11 | Not public |
| Exhibit Claimant | 2026-03-11 | Not public |
| Exhibit Claimant | 2026-03-11 | Not public |
| Receipt | 2026-03-09 | Not public |
| Cover sheet | 2026-03-09 | Not public |
| Exhibit Claimant | 2026-03-09 | Not public |
| Further pleadings | 2026-03-09 | Not public |
| Receipt | 2026-03-09 | Not public |
| Cover sheet | 2026-03-09 | Not public |
| Document | 2026-03-09 | Not public |
| action.issueOrder.order | 2026-03-09 | Not public |
| Order | 2026-03-09 | Public |
| action.phaseChange.oralPhaseOpen | 2026-03-06 | Not public |
| action.issueOrder.order | 2026-03-06 | Not public |
| Order | 2026-03-06 | Public |
| action.phaseChange.interimPhaseOpen | 2026-02-20 | Not public |
| action.issueOrder.order | 2026-02-12 | Not public |
| Order | 2026-02-12 | Public |
| action.summons.oralHearing | 2025-12-11 | Not public |
| Summons | 2025-12-11 | Not public |
| Cover | 2025-08-28 | Not public |
| 2025-08-28 Duplik Canfield im Verfahren zur Aenderung des Patents_signed | 2025-08-28 | Not public |
| Cover | 2025-07-28 | Not public |
| Replik Antrag auf Änderung des Patents | 2025-07-28 | Not public |
| Acknowledgement-of-lodging | 2025-07-28 | Not public |
| Duplik Nichtigkeitswiderklage | 2025-07-28 | Not public |
| Acknowledgement-of-lodging | 2025-07-28 | Not public |
| Duplik Nichtigkeitswiderklage | 2025-07-28 | Not public |
| Panel-Appointment | 2025-07-11 | Not public |
| Hearing-Dates | 2025-07-02 | Not public |
| Terminbestimmung Widerklage | 2025-07-02 | Public |
| Hearing-Dates | 2025-07-02 | Not public |
| Acknowledgement-of-lodging | 2025-07-01 | Not public |
| 2025-06-30_R_32_Erwiderung_Canfield_auf_Hilfsantrag_signed.pdf | 2025-07-01 | Not public |
| Acknowledgement-of-lodging | 2025-07-01 | Not public |
| 2025-06-30_R_32_Erwiderung_Canfield_auf_Hilfsantrag_signed.pdf | 2025-07-01 | Not public |
| Acknowledgement-of-lodging | 2025-07-01 | Not public |
| 2025-06-30_R_32_Erwiderung_Canfield_auf_Hilfsantrag_signed.pdf | 2025-07-01 | Not public |
| Acknowledgement-of-lodging | 2025-07-01 | Not public |
| 2025-06-30_R_32_Erwiderung_Canfield_auf_Hilfsantrag_signed.pdf | 2025-07-01 | Not public |
| Acknowledgement-of-lodging | 2025-07-01 | Not public |
| 2025-06-30_R_32_Erwiderung_Canfield_auf_Hilfsantrag_signed.pdf | 2025-07-01 | Not public |
| Acknowledgement-of-lodging | 2025-07-01 | Not public |
| 2025-06-30_Replik_Nichtigkeitswiderklage_Canfield_signed.pdf | 2025-07-01 | Not public |
| Acknowledgement-of-lodging | 2025-07-01 | Not public |
| Anlage_KAP_NWK_19_-_en | 2025-07-01 | Not public |
| Anlage_KAP_NWK_20_-_en | 2025-07-01 | Not public |
| 2025-06-30_Replik_Nichtigkeitswiderklage_Canfield_signed.pdf | 2025-07-01 | Not public |
| Anlage_KAP_NWK_21_-_en | 2025-07-01 | Not public |
| Acknowledgement-of-lodging | 2025-04-29 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-04-29 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-04-28 | Not public |
| Acknowledgement-of-lodging | 2025-04-28 | Not public |
| Anlage LRN 6 | 2025-04-28 | Not public |
| Anlage LRN 7 | 2025-04-28 | Not public |
| Anlage LRN 2 | 2025-04-28 | Not public |
| Anlage LRN 8 | 2025-04-28 | Not public |
| Anlage LRN 5 | 2025-04-28 | Not public |
| Anlage LRN 3 | 2025-04-28 | Not public |
| Anlage LRN 10 | 2025-04-28 | Not public |
| Anlage LRN 4 | 2025-04-28 | Not public |
| Anlage LRN 9 | 2025-04-28 | Not public |
| Anlage LRN 11 | 2025-04-28 | Not public |
| Anlage LRN 1 | 2025-04-28 | Not public |
| Erwiderung auf Nichtigkeitswiderklage | 2025-04-28 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-04-28 | Not public |
| Acknowledgement-of-lodging | 2025-04-28 | Not public |
| Anlage LRN 4 | 2025-04-28 | Not public |
| Anlage LRN 9 | 2025-04-28 | Not public |
| Anlage LRN 8 | 2025-04-28 | Not public |
| Anlage LRN 7 | 2025-04-28 | Not public |
| Erwiderung auf Nichtigkeitswiderklage | 2025-04-28 | Not public |
| Anlage LRN 10 | 2025-04-28 | Not public |
| Anlage LRN 5 | 2025-04-28 | Not public |
| Anlage LRN 1 | 2025-04-28 | Not public |
| Anlage LRN 2 | 2025-04-28 | Not public |
| Anlage LRN 6 | 2025-04-28 | Not public |
| Anlage LRN 11 | 2025-04-28 | Not public |
| Anlage LRN 3 | 2025-04-28 | Not public |
| Hilfsantrag Patent Anspruch 1 | 2025-04-28 | Not public |
| Document from EPO | 2025-03-05 | Not public |
| communicationCheck | 2025-03-05 | Not public |
| Document from EPO | 2025-03-05 | Not public |
| communicationCheck | 2025-03-05 | Not public |
| Document from EPO | 2025-03-04 | Not public |
| Notification Of Service | 2025-03-04 | Not public |
| Zustellung CC an Klaegervetreter | 2025-03-04 | Not public |
| Acknowledgement of access to case | 2025-03-04 | Not public |
| Letter-for-Service | 2025-03-03 | Not public |
| Panel-Appointment | 2025-03-03 | Not public |
| EPO-Request-for-case-pending | 2025-03-03 | Not public |
| Acknowledgement-of-lodging | 2025-03-03 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-03-03 | Not public |
| Anlage_KAP_NWK_06_-de | 2025-02-28 | Not public |
| Anlage_KAP_NWK_13_-_en | 2025-02-28 | Not public |
| Anlage_KAP_NWK_03_-_en | 2025-02-28 | Not public |
| Anlage_KAP_NWK_11_-_en | 2025-02-28 | Not public |
| Anlage_KAP_NWK_16_-_en | 2025-02-28 | Not public |
| Anlage_KAP_NWK_17_-_en | 2025-02-28 | Not public |
| Anlage_KAP_NWK_02_-_de | 2025-02-28 | Not public |
| Anlage_KAP_NWK_12_-_en | 2025-02-28 | Not public |
| Anlage_KAP_NWK_01_-_de | 2025-02-28 | Not public |
| Anlage_KAP_NWK_07_-_fr | 2025-02-28 | Not public |
| Anlage_KAP_NWK_08_-_de | 2025-02-28 | Not public |
| Anlage_KAP_NWK_10_-_en | 2025-02-28 | Not public |
| Anlage_KAP_NWK_18_-_de | 2025-02-28 | Not public |
| Anlage_KAP_NWK_09_-_de | 2025-02-28 | Not public |
| Anlage_KAP_NWK_04_-_en | 2025-02-28 | Not public |
| 2025-02-28_Nichtigkeitswiderklage_signed | 2025-02-28 | Not public |
| Anlage_KAP_NWK_15_-_en | 2025-02-28 | Not public |
| Anlage_KAP_NWK_05_-_en | 2025-02-28 | Not public |
| Anlage_KAP_NWK_14_-_en | 2025-02-28 | Not public |
| Anlage_KAP_NWK_07a_-_de | 2025-02-28 | Not public |
An infringing act established in one Contracting Member State (Germany, even under a procedural 'carve out') is sufficient to issue an injunction covering all Contracting Member States where the patent is in force under Art. 34 UPCA
ClaimantLegal basis: Art. 34 UPCAThe dual optics feature of claim 1 does not require two separate optical systems without moving parts; the patent's teaching exploits depth of field and claim 1 does not exclude moving parts
ClaimantLegal basis: Art. 69 EPC / claim construction principlesConvergence of light beams at the target distance constitutes the required 'signalling' under claim 1 without a temporally separate second step
ClaimantLegal basis: Art. 69 EPC / claim constructionInfringement of claims 1 and 14 by Canfield Vectra H2, including use of the method in clinical study support and training
ClaimantLegal basis: Art. 25(a) and 25(b) UPCANo prescription under Art. 72 UPCA because claimant only acquired knowledge of infringing acts in July/August 2020 (when infringement analysis and warning letter were issued)
ClaimantLegal basis: Art. 72 UPCAProvisional damages of EUR 20,000 are warranted under R. 119 RoP to cover anticipated costs of the quantum proceedings
ClaimantLegal basis: R. 119 RoP; Art. 68 UPCAProvisional cost reimbursement of EUR 90,000 for the counterclaim for revocation is justified at 50% of the reimbursement ceiling
ClaimantLegal basis: Art. 69(1) UPCA; R. 150.2 RoP
Lack of inventive step of EP 3 156 843 based on multiple prior art combinations including Wolf 'Elements of Photogrammetry', VECTRA H1 User Guide, WO 2010/012722, WO 2010/097572, and related art
RespondentLegal basis: Art. 138(1)(a) EPC; Art. 65 UPCAClaim 1 requires dual optics without moving parts and with two fully separate optical systems
RespondentLegal basis: Art. 69 EPC / claim constructionSignalling must be a distinct temporally separate step following establishment of target distance
RespondentLegal basis: Art. 69 EPC / claim constructionClaimant lacked passive standing against Defendant 1 for acts in non-German contracting member states because only German infringement was alleged and Germany was carved out
RespondentLegal basis: Art. 34 UPCAInjunction should be territorially limited per defendant to countries where that defendant's infringing acts were individually proven
RespondentLegal basis: Art. 34 UPCA; UPC_CFI_440/2023Claims for damages and ancillary relief accruing before 26 September 2019 are time-barred under Art. 72 UPCA
RespondentLegal basis: Art. 72 UPCAEnforcement should be stayed pending provision of a bank guarantee of EUR 1,800,000 due to catastrophic potential harm to respondents
RespondentLegal basis: Art. 82(2) UPCA; R. 352.1 RoPDisclosure obligation should be subject to a confidentiality order restricting access to claimant's legal representatives and one non-sales employee
RespondentLegal basis: Art. 67 UPCAThree US family patents were held invalid by the PTAB in IPR proceedings on substantially the same prior art, indicating the patent lacks inventive step
RespondentLegal basis: Art. 138(1)(a) EPC